Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value

Malignant pleural mesothelioma (MPM) is a rare but aggressive malignancy with a poor prognosis. Because of this tumor rarity and overlapping histologic features with other malignancy types, the histopathological findings and diagnostic immunohistochemical workup are essential in establishing the fin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaker, Nada, Wu, Douglas, Abid, Abdul Majeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Timely Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826471/
https://www.ncbi.nlm.nih.gov/pubmed/36069384
http://dx.doi.org/10.1002/dc.25053
_version_ 1784866859704647680
author Shaker, Nada
Wu, Douglas
Abid, Abdul Majeed
author_facet Shaker, Nada
Wu, Douglas
Abid, Abdul Majeed
author_sort Shaker, Nada
collection PubMed
description Malignant pleural mesothelioma (MPM) is a rare but aggressive malignancy with a poor prognosis. Because of this tumor rarity and overlapping histologic features with other malignancy types, the histopathological findings and diagnostic immunohistochemical workup are essential in establishing the final diagnosis of MPMs. We aimed to review the diagnostic criteria, WHO tumor classification updates, and immunohistochemical staining markers diagnostic value to achieve an appropriate clinical diagnosis.
format Online
Article
Text
id pubmed-9826471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98264712023-01-09 Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value Shaker, Nada Wu, Douglas Abid, Abdul Majeed Diagn Cytopathol Timely Review Malignant pleural mesothelioma (MPM) is a rare but aggressive malignancy with a poor prognosis. Because of this tumor rarity and overlapping histologic features with other malignancy types, the histopathological findings and diagnostic immunohistochemical workup are essential in establishing the final diagnosis of MPMs. We aimed to review the diagnostic criteria, WHO tumor classification updates, and immunohistochemical staining markers diagnostic value to achieve an appropriate clinical diagnosis. John Wiley & Sons, Inc. 2022-09-07 2022-11 /pmc/articles/PMC9826471/ /pubmed/36069384 http://dx.doi.org/10.1002/dc.25053 Text en © 2022 The Authors. Diagnostic Cytopathology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Timely Review
Shaker, Nada
Wu, Douglas
Abid, Abdul Majeed
Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
title Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
title_full Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
title_fullStr Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
title_full_unstemmed Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
title_short Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
title_sort cytology of malignant pleural mesothelioma: diagnostic criteria, who classification updates, and immunohistochemical staining markers diagnostic value
topic Timely Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826471/
https://www.ncbi.nlm.nih.gov/pubmed/36069384
http://dx.doi.org/10.1002/dc.25053
work_keys_str_mv AT shakernada cytologyofmalignantpleuralmesotheliomadiagnosticcriteriawhoclassificationupdatesandimmunohistochemicalstainingmarkersdiagnosticvalue
AT wudouglas cytologyofmalignantpleuralmesotheliomadiagnosticcriteriawhoclassificationupdatesandimmunohistochemicalstainingmarkersdiagnosticvalue
AT abidabdulmajeed cytologyofmalignantpleuralmesotheliomadiagnosticcriteriawhoclassificationupdatesandimmunohistochemicalstainingmarkersdiagnosticvalue

Ejemplares similares